Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 18,716 | 27,648 | 23,575 | 21,624 | 20,132 |
| Gross Profit | 18,716 | 27,648 | 23,575 | 21,624 | 20,132 |
| Operating Expenses | 52,563 | 58,057 | 57,302 | 55,471 | 49,832 |
| Operating Income | -33,847 | -30,409 | -33,727 | -33,847 | -29,700 |
| Other Income | 255 | 258 | 333 | 439 | 545 |
| Pre-tax Income | -33,592 | -30,151 | -33,394 | -33,408 | -29,155 |
| Income Tax | N/A | -36 | -8,795 | -9,384 | -7,110 |
| Net Income Continuous | -33,592 | -30,115 | -24,599 | -24,024 | -22,045 |
| Net Income | $-33,592 | $-30,115 | $-24,599 | $-24,024 | $-22,045 |
| EPS Basic Total Ops | -1.63 | -1.48 | -1.23 | -1.19 | -1.09 |
| EPS Basic Continuous Ops | -1.63 | -1.48 | -1.22 | -1.19 | -1.09 |
| EPS Diluted Total Ops | -1.63 | -1.48 | -1.23 | -1.19 | -1.09 |
| EPS Diluted Continuous Ops | -1.63 | -1.48 | -1.22 | -1.19 | -1.09 |
| EBITDA(a) | $-32,643 | $-29,083 | $-32,321 | $-32,464 | $-28,341 |